| Study/Grant |
Prinicpal Investigator |
Program Director |
Funding |
Dates |
| An Open-label, Multicenter Study With Follow-up Evaluating the Safety and Efficacy of Varenicline Tartrate in Comparison to Transdermal Nicotine Patch for Smoking Cessation |
Lori Pbert |
Susan Druker |
Pfizer, Inc. |
2005-2006 |
| A Twelve-Week, Double-Blind, Placebo-Controlled, Randomized, Multi-center Study with Follow-up Evaluating the Safety and Efficacy of Varenicline Tartrate (CP-526,555) in Comparison to Zyban® for Smoking Cessation |
Lori Pbert |
Susan Druker |
Pfizer, Inc. |
2003-2005 |
| Evaluation of a School Nurse-Delivered Tobacco Cessation Intervention for Adolescents |
Lori Pbert |
Susan Druker |
MDPH |
2002-2004 |
| Policy to Support Tobacco Treatment in Health Care |
Judith Ockene, Lori Pbert, Jane Zapka (Co-PIs) |
Denise Jolicoeur |
NIH CA86282 |
2000-2005 |
| Provider and Peer Delivered Youth Smoking Intervention |
Lori Pbert |
Susan Druker |
NIH R01 CA80254 |
1999-2004 |
| Developing and Testing New HEDIS Smoking Measures |
Lori Pbert, Jack Hollis, Susan Druker |
Nancy Vuckovic |
RWJF |
1999-2000 |
| A Multi-Center, Randomized, Parallel, Placebo-Controlled, One-Year Study of the Efficacy and Safety of Zyban Versus Placebo as Aids to Smoking Cessation Treatment in Adult Cigarette Smokers Previously Treated with Bupropion |
Lori Pbert |
Susan Druker |
Glaxo Wellcome |
1999-2000 |
| A Multi-Center, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy of Buspirone (15 mg and 30 mg) as an Aid in Smoking Cessation |
Lori Pbert |
Susan Druker |
Bristol-Meyers Squibb/PharmaNet |
1999-2000 |
| Smoking Intervention for Low-Income Pregnant Women |
Judith Ockene,
Lori Pbert (Co-PI) |
Deb Bonollo |
NIH R01 HL51319 |
1996-2001 |
| |
|
|
|
|
| |
|
|
|
|